Le Lézard
Classified in: Science and technology
Subject: PER

Isola Appoints Troy Ruhrer As New Chief Financial Officer


CHANDLER, Ariz., Sept. 12, 2018 /PRNewswire/ -- Isola Group, a market leader in copper-clad laminates and dielectric prepreg materials used to fabricate advanced multilayer printed circuit boards (PCBs), today announced it has promoted Troy Ruhrer, formerly Vice President, Finance to the role of Chief Financial Officer and member of the Executive Leadership Team.

 "Troy's promotion validates the strength of our management team and our commitment to growing our Arizona presence," said Jeff Waters, President and CEO of Isola.  "Troy has done an excellent job as the interim head of our finance organization and has demonstrated the capability, competence and maturity to excel as CFO for the organization. I'm very excited to formally appoint Troy to this position where he will continue to make a positive impact on the financial management and strength of the organization."

Mr. Ruhrer joined Isola in 2007 as Director of Accounting and then became Director of Worldwide Accounting and Financial Reporting in 2014. In 2016 he was promoted to Chief Accountant and then to Vice President, Finance in 2017.

Mr. Ruhrer, who began his career in public accounting, has over 22 years of financial management experience. Prior to joining Isola he served as Vice President of West Coast Operations for Amandi Services, Inc., a privately held electronics management and recycling company. Prior to his role at Amandi Services, Inc., Mr. Ruhrer held various financial management positions at several public and private companies. Mr. Ruhrer obtained his Bachelor of Arts degree in Accounting and Business Administration from Doane University.

About Isola
Isola Group, headquartered in Chandler, Arizona, is a global material sciences company focused on designing, developing, manufacturing and marketing copper-clad laminates and dielectric prepregs used to fabricate advanced multi-layer printed circuit boards. Isola's high-performance materials are used in sophisticated electronic applications in the communications infrastructure, cloud computing, automotive, military, medical and aerospace markets. Isola has over 1600 employees with technical support, sales, manufacturing and R&D facilities in Asia, Europe and North America.  For more information visit our website at https://www.isola-group.com/.

WEBSITE: (HTTPS://WWW.ISOLA-GROUP.COM/)
PRODUCTS: (HTTPS://WWW.ISOLA-GROUP.COM/PRODUCTS)
SERVICES AND SUPPORT: (HTTPS://WWW.ISOLA-GROUP.COM/SERVICES -SUPPORT/)
NEWS & RESOURCES (HTTPS://WWW.ISOLA-GROUP.COM/NEWS-RESOURCES/)
ABOUT US (HTTPS://WWW.ISOLA-GROUP.COM/ABOUT-US)

 

SOURCE Isola Group


These press releases may also interest you

at 09:10
TransAct Technologies Incorporated , a global leader in software-driven technology and printing solutions for high-growth markets, announced today that it will release its first quarter 2024 results before the market opens on Tuesday, May 7, 2024,...

at 09:10
CobbleStone Software ? a recognized Leader in contract lifecycle management (CLM) according to the SPARK Matrixtm Report? continues to inform professionals of the benefits of implementing an effective, AI-based CLM software within their...

at 09:05
Aspen Technology, Inc. , a global leader in industrial software, today introduced AspenTech Strategic Planning for Sustainability Pathwaystm ? a new and unique integrated modelling and optimization solution that aims to guide companies in carbon...

at 09:00
Dental Care Acworth is thrilled to utilize this remarkable innovation and offer patients unbiased, objective and standardized dental care that they know they can trust. The AI solutions Pearl delivers can assist dental...

at 09:00
The Ceph Foundation, the global community dedicated to fostering the growth and advancement of Ceph, is excited to announce the release of Ceph Squid, which comes with several performance and space efficiency features along with enhanced protocol...

at 09:00
Amgen today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1...



News published on and distributed by: